 |
 |
IMMUNOLOGIST Jacques Miller did not win this year’s Nobel Prize in Physiology or Medicine. He didn’t win it last year or the year before that. In fact, the French-born Australian has […]
WELCOME to The Pipeline, the place where Cartherics team members share occasional news and views.
To get things rolling, Communications Adviser Leigh Dayton talked with cancer immunologist Ashleigh Unsworth, Cartherics’ latest recruit. Ashleigh joins the company from Peter MacCallum Cancer Centre where she conducted breast cancer research while […]
Health Minister Greg Hunt promotes the prospects for immunotherapy on The Today Show 12 October 2018
‘The Nobel Assembly at Karolinska Institutet has today decided to award the 2018 Nobel Prize in Physiology or Medicine jointly to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation’.
Read the summary in the link NOBEL medicine2018 release
Photograph: L-R: Dr Michael Gantier, Stuart Emmerson, Dr Nick Boyd and Dr Shivani Pasricha
Researchers and students have pitched their innovative ‘Big Ideas’ tackling health conditions ranging from tackling Legionnaires disease to improving exercise science to a panel of research and commercialisation experts.
It was all part of the Next Big Idea […]
A student development evening was held on 13 August 2018 at Monash University Clayton where Professor Graham Jenkin a represented Cartherics Pty Ltd. More information regarding our PhD projects is available on our Opportunities page.
What open days are for ……
Our organising committee has been working relentlessly on this inaugural world conference having now assembled an excellent program of 40+ national and international opinion leaders. This conference is indeed something out of the ordinary.
Immunotherapy is on the cusp of revolutionising cancer treatment with some in the field even considering the potential of cure. With […]
Cartherics has been advised by the Hon Craig Laundy MP (Assistant Minister for Industry, Innovation and Science) that its application “Allogeneic Stem Cell Cancer Immunotherapies” in the 4th Cooperative Research Centres (CRC) Project Funding round has been successful.
Cartherics’ application was one of just 15 successful applications out of a total of 70 received in the 4th […]
Cartherics’ mission is the development of novel, immune cell therapy products for the treatment of cancer, endometriosis and Alzheimer’s disease.
Stay informed about our latest news and developments
© Copyright 2022 | Cartherics Pty ltd
